AI assistant
Sending…
Krystal Biotech, Inc. — Director's Dealing 2018
May 24, 2018
31006_dirs_2018-05-24_2ca49343-1f90-427f-b8a5-339439e23344.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Krystal Biotech, Inc. (KRYS)
CIK: 0001711279
Period of Report: 2018-03-08
Reporting Person: Riley Antony A (Chief Financial Officer)
More from Krystal Biotech, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 4
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4